Favorable Changes in Fasting Glucose in a 6-month Self-Monitored Lifestyle Modification Programme Inversely Affects Spexin Levels in Females with Prediabetes
- PMID: 31263247
- PMCID: PMC6602932
- DOI: 10.1038/s41598-019-46006-0
Favorable Changes in Fasting Glucose in a 6-month Self-Monitored Lifestyle Modification Programme Inversely Affects Spexin Levels in Females with Prediabetes
Abstract
Spexin (SPX) is a novel peptide thought to have a role in various metabolic regulations. Given its presumed body-weight regulatory functions, we aimed to determine whether lifestyle intervention programs on weight loss and fasting glucose (FG) improvement among people with impaired glucose regulation also alter levels of circulating SPX. A total of 160 Saudi adult males and females with prediabetes were randomly selected from a larger cohort (N = 294) who underwent a 6-month lifestyle modification program to improve their glycemic status. Participants were split into two groups based on differences in glucose levels post-intervention, with the first 50% (improved group) having the most significant reduction in FG. SPX was measured at baseline and after 6 months. Changes in SPX was significant only in the improved group [baseline: median (Q1-Q3) of 164 pg/ml (136-227) vs follow-up: 176 pg/ml (146-285); p < 0.01]. When stratified by sex, the significant increase was observed only in females [159 pg/ml (127-252) vs 182.5 (152,369.1); p < 0.01]. Furthermore, SPX levels showed a significant inverse association with FG (β = -0.22, p = 0.003) even after adjustment with age and BMI, again only in females. Circulating SPX levels increase over time in people with prediabetes, particularly women who responded favorably in a 6-month lifestyle intervention program. Whether an unknown mechanism regulating the sexual disparity seen in SPX levels post-intervention exists should be further investigated using a larger sample size.
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Novel insights on the role of spexin as a biomarker of obesity and related cardiometabolic disease.Int J Obes (Lond). 2021 Oct;45(10):2169-2178. doi: 10.1038/s41366-021-00906-2. Epub 2021 Jul 12. Int J Obes (Lond). 2021. PMID: 34253845 Review.
-
Effects of A 12-Month Intensive Lifestyle Monitoring Program in Predominantly Overweight/Obese Arab Adults with Prediabetes.Nutrients. 2020 Feb 12;12(2):464. doi: 10.3390/nu12020464. Nutrients. 2020. PMID: 32059477 Free PMC article. Clinical Trial.
-
Circulating spexin levels are influenced by the presence or absence of gestational diabetes.Cytokine. 2019 Jan;113:291-295. doi: 10.1016/j.cyto.2018.07.023. Epub 2018 Jul 19. Cytokine. 2019. PMID: 30031679 Clinical Trial.
-
Spexin Levels Are Associated with Metabolic Syndrome Components.Dis Markers. 2018 Sep 4;2018:1679690. doi: 10.1155/2018/1679690. eCollection 2018. Dis Markers. 2018. PMID: 30254709 Free PMC article.
-
Impact of spexin on metabolic diseases and inflammation: An updated minireview.Exp Biol Med (Maywood). 2022 Apr;247(7):567-573. doi: 10.1177/15353702211072443. Epub 2022 Jan 22. Exp Biol Med (Maywood). 2022. PMID: 35068225 Free PMC article. Review.
Cited by
-
Does exercise during a ketogenic diet effectively alter appetite sensation, appetite-regulating hormones, and body composition?Exp Biol Med (Maywood). 2022 Nov;247(21):1898-1906. doi: 10.1177/15353702221113862. Epub 2022 Aug 3. Exp Biol Med (Maywood). 2022. PMID: 35920294 Free PMC article. Clinical Trial.
-
Serum Spexin is Correlated with Lipoprotein(a) and Androgens in Female Adolescents.J Clin Med. 2019 Dec 2;8(12):2103. doi: 10.3390/jcm8122103. J Clin Med. 2019. PMID: 31810188 Free PMC article.
-
Sex-Specific Signature in the Circulating NLRP3 Levels of Saudi Adults with Metabolic Syndrome.J Clin Med. 2021 Jul 26;10(15):3288. doi: 10.3390/jcm10153288. J Clin Med. 2021. PMID: 34362072 Free PMC article.
-
Novel insights on the role of spexin as a biomarker of obesity and related cardiometabolic disease.Int J Obes (Lond). 2021 Oct;45(10):2169-2178. doi: 10.1038/s41366-021-00906-2. Epub 2021 Jul 12. Int J Obes (Lond). 2021. PMID: 34253845 Review.
-
Elevated serum METRNL levels in children with obesity and its association with insulin resistance.Eur J Pediatr. 2025 Aug 9;184(9):543. doi: 10.1007/s00431-025-06362-8. Eur J Pediatr. 2025. PMID: 40782135 Free PMC article.